Published in J Pathol on December 01, 1973
The ultrastructure of the anastomosed vein of experimental arteriovenous fistulae in sheep. Am J Pathol (1974) 0.95
Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol (1987) 5.33
Restrictive cardiomyopathy. N Engl J Med (1997) 3.29
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Developmental regulation of cryptdin, a corticostatin/defensin precursor mRNA in mouse small intestinal crypt epithelium. J Cell Biol (1989) 2.81
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation (2001) 2.71
Specific Tissue Reaction to Phospholipids: A Suggested Explanation for the Similarity of the Lesions of Silicosis and Pulmonary Tubercolosis. Can Med Assoc J (1937) 2.67
Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol (1992) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies. Am J Hum Genet (2001) 2.13
The Cellular Reaction to Silica. Can Med Assoc J (1935) 2.11
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell (1986) 1.98
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology (2006) 1.89
Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. J Vasc Surg (2001) 1.77
Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. Circulation (1999) 1.74
Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation (2000) 1.70
An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69
Morphology after transluminal angioplasty in human beings. N Engl J Med (1981) 1.69
Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation (1995) 1.68
Aberrant coronary artery origin from the aorta. Report of 18 patients, review of literature and delineation of natural history and management. Circulation (1979) 1.67
Inhibition of tissue factor limits the growth of venous thrombus in the rabbit. J Thromb Haemost (2003) 1.64
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
Release of active tissue factor by human arterial smooth muscle cells. Circ Res (2000) 1.57
The ultrastructure of early platelet aggregation in vivo. Am J Pathol (1967) 1.56
Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol (1990) 1.55
An appraisal of the epidemic rise of coronary heart disease and its decline. Lancet (1987) 1.53
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation. J Am Coll Cardiol (1990) 1.51
Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation (1982) 1.44
The basal attachment of endothelial cells. J Ultrastruct Res (1966) 1.44
Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation (1991) 1.44
Ultrastructure of the carotid body. J Cell Biol (1966) 1.42
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation (1997) 1.39
"Borderline" myocarditis: an indication for repeat endomyocardial biopsy. J Am Coll Cardiol (1990) 1.39
Atherosclerosis: usage and misusage. J Intern Med (1998) 1.39
Coronary heart disease death certificate diagnoses. N Z Med J (1988) 1.39
The National Heart Foundation of Australia Pick the Tick Program. Med J Aust (1992) 1.38
The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol (1999) 1.37
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation (1989) 1.35
In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation (2000) 1.35
Haemodynamic production of lipid deposition, intimal teats, mural dissection and thrombosis in the blood vessel wall. Proc R Soc Lond B Biol Sci (1974) 1.34
Ventricular septal rupture: a review of clinical and physiologic features and an analysis of survival. Circulation (1981) 1.34
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol (1999) 1.33
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem (1997) 1.29
Threshold ultrasonic dosages for structural changes in the mammalian brain. J Acoust Soc Am (1970) 1.29
Collagen fibril bundles: a branching assembly unit in tendon morphogenesis. Development (1989) 1.28
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury. Circulation (2001) 1.27
In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest (1996) 1.26
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation. Circulation (1988) 1.25
Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol (1977) 1.23
Determination of mitral valve area by cross-sectional echocardiography. Ann Intern Med (1978) 1.19
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation (1996) 1.18
Identification of active tissue factor in human coronary atheroma. Circulation (1996) 1.18
Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost (1997) 1.18
Myocardial cell death and apoptosis in hibernating myocardium. J Am Coll Cardiol (1997) 1.18
Venous endothelium of experimental arteriovenous fistulas in rabbits. Circ Res (1972) 1.15
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest (1988) 1.14
Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci (1982) 1.14
Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol (1982) 1.13
Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation (1994) 1.12
Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 1.10
Biosynthesis and secretion of proatrial natriuretic factor by cultured rat cardiocytes. Science (1985) 1.10
Expression of the integrin alpha8beta1 during pulmonary and hepatic fibrosis. Am J Pathol (2000) 1.10
Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation (1980) 1.09
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation (1996) 1.08
Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis (2000) 1.08
Non-Q-wave infarction and ostial left coronary obstruction due to giant Lambl's excrescences of the aortic valve. Circulation (1999) 1.07
Scanning electron microscopy after coronary transluminal angioplasty of normal canine coronary arteries. Am J Cardiol (1980) 1.07
Human vascular smooth muscle cells possess functional CCR5. J Biol Chem (2000) 1.06
Cross-sectional echocardiographic examination of the interatrial septum. Circulation (1977) 1.06
Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost (2011) 1.05
Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest (2001) 1.05
Relationship of cerebral aneurysms and medial raphes. Surg Neurol (1999) 1.05
Transluminal coronary angioplasty of postmortem human hearts. Am J Cardiol (1981) 1.05
Plaque rupture, thrombosis, and therapeutic implications. Haemostasis (1996) 1.04
Flaws in the lipid hypothesis of atherogenesis. Pathology (1988) 1.04
Lymphedema, lymphocytic myocarditis, and sarcoidlike granulomatosis. Manifestations of Whipple's disease. JAMA (1989) 1.04
Haemodynamically-induced intimal tears in experimental U-shaped arterial loops as seen by scanning electron microscopy. Br J Exp Pathol (1985) 1.02
Experimental angioplasty: lessons from the laboratory. AJR Am J Roentgenol (1980) 1.02
Noninvasive visualization of the left main coronary artery by cross-sectional echocardiography. Circulation (1976) 1.02
Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation (1979) 1.02
The effect of hypercholesterolemia on aortic endothelium studied en face. Atherosclerosis (1976) 1.02
Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation (2000) 1.02
Selective ablation of atheromas using a flashlamp-excited dye laser at 465 nm. Proc Natl Acad Sci U S A (1986) 1.02
An improved immunofluorescence technique for the histological examination of blood vessel tissue. Acta Histochem (1989) 1.02
Cardiac allograft vasculopathy in partially inbred miniature swine. I. Time course, pathology, and dependence on immune mechanisms. J Thorac Cardiovasc Surg (1996) 1.01
Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol (1983) 1.01
Tissue Reaction to Sericite. Can Med Assoc J (1935) 1.00
Ischemic heart disease in systemic lupus erythematosus in the young patient: report of six cases. Am J Cardiol (1982) 1.00
Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation (1990) 0.99
The concept of cause in disease. J Chronic Dis (1985) 0.99